Quest Diagnostics DGX invests in advanced diagnostics to deliver and scale innovative services that improve patient care and drive growth. The company seeks growth through disciplined, value-accretive ...

In the fast-growing diagnostics testing market, Hologic HOLX and Quest Diagnostics DGX stand out as two prominent players, ...

Revenues grew 13.1%, including 6.8% organic growth driven by broad-based adoption of our clinical innovations, contributions ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Hims & Hers Health stock has seen its fair value estimate trimmed from about $46.00 to roughly $44.36 per share, even as analysts grow more optimistic about its long term revenue trajectory. Stronger ...

In recent weeks, Oracle announced it unanimously elected former Quest Diagnostics CEO Stephen Rusckowski to its board, while ...

Although many companies using kiosks have some level of accessibility built in -- compliant height, reachable screens or ...

Hims & Hers shows platform expansion, verticalization, new Labs offerings, slower FCF growth and strong long-term revenue targets. Learn why HIMS stock is a buy.

This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated ...

Welcome to the great plains. When next Major League Baseball hosts a World Series it will have been a decade since any ...

This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated ...

Adversa AI, the pioneer in Agentic AI Security and Continuous AI Red Teaming, has been named the winner of the Cloud Security Alliance's Startup Pitchapalooza 2025, emerging at the top of a highly ...